Quarterly ResultMay 18, 2026, 04:32 PM
GoHealth Faces Substantial Doubt on Going Concern; Q1 Revenue Down 94.6%
AI Summary
GoHealth, Inc. reported substantial doubt about its ability to continue as a going concern within the next twelve months, citing potential non-compliance with its liquidity covenant and ongoing discussions with lenders regarding strategic alternatives. For the first quarter of 2026, net revenues plummeted 94.6% to $11.9 million compared to $221.0 million in Q1 2025. The net loss attributable to GoHealth, Inc. significantly widened to $37.2 million, or $2.36 per share, from a $4.4 million loss, or $0.52 per share, in the prior year period.
Key Highlights
- Substantial doubt about GoHealth's ability to continue as a going concern.
- Q1 2026 net revenues plunged 94.6% to $11.9 million from $221.0 million YoY.
- Net loss attributable to GoHealth, Inc. widened to $37.2 million from $4.4 million YoY.
- Diluted EPS was a loss of $2.36, compared to a loss of $0.52 in Q1 2025.
- Operating income shifted to a $34.8 million loss from a $6.7 million profit YoY.
- Interest expense increased to $30.8 million from $16.0 million YoY.
- Long-term debt, net, rose to $650.8 million from $636.7 million QoQ.
Price Impact
More from GOCO